Literature DB >> 10536663

Repolarizing currents in ventricular myocytes from young patients with tetralogy of Fallot.

P Schaffer1, B Pelzmann, E Bernhart, P Lang, H Mächler, B Rigler, B Koidl.   

Abstract

OBJECTIVE: It was the aim of our study to describe repolarizing currents in ventricular myocytes isolated from children with tetralogy of Fallot. This is the first report on outward currents in ventricular myocytes from children.
METHODS: Ventricular myocytes were isolated from tissue samples of the outflow tract of the right ventricle which were obtained during corrective surgery of tetralogy of Fallot. Action potentials and whole-cell currents were recorded with the patch clamp technique at a temperature of 36-37 degrees C.
RESULTS: The mean resting potential was -71.7 +/- 1.92 mV, action potential amplitude was 110 +/- 2.96 mV and action potential duration at 90% repolarization was 794 +/- 99.5 ms (n = 12). In four out of 12 myocytes early afterdepolarizations (EADs) were observed. Upon hyperpolarization Ba(2+)-sensitive inward currents similar to the inward rectifier current (IKl) could be observed. The current density at -120 mV was -22.8 +/- 2.47 pA/pF (n = 14). A transient outward current (Itol) could be recorded in all myocytes studied, the current density varied from 0.3 to 8.6 pA/pF with a mean of 3.77 +/- 0.47 pA/pF at +40 mV (n = 38). Recovery of Itol from inactivation was fast (70% recovery within 100 ms), rate-dependent reduction amounted to 38.2% at 4 Hz. A delayed rectifier current was seen in only two out of 38 myocytes (rapid component IKr).
CONCLUSIONS: The electrophysiological characteristics of right ventricular myocytes isolated from children with tetralogy of Fallot resemble in most cases subendocardial myocytes from adults. The most prominent difference is a fast recovery from inactivation as well as a small rate dependent reduction of Itol. The observed EADs may have clinical implications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536663     DOI: 10.1016/s0008-6363(99)00118-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Inter-individual variability in the pre-clinical drug cardiotoxic safety assessment--analysis of the age-cardiomyocytes electric capacitance dependence.

Authors:  Sebastian Polak; Kamil Fijorek
Journal:  J Cardiovasc Transl Res       Date:  2012-03-13       Impact factor: 4.132

2.  High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

Authors:  Junyi Ma; Liang Guo; Steve J Fiene; Blake D Anson; James A Thomson; Timothy J Kamp; Kyle L Kolaja; Bradley J Swanson; Craig T January
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

3.  The Human Ether-a-go-go-related Gene (hERG) Potassium Channel Represents an Unusual Target for Protease-mediated Damage.

Authors:  Shawn M Lamothe; Jun Guo; Wentao Li; Tonghua Yang; Shetuan Zhang
Journal:  J Biol Chem       Date:  2016-08-08       Impact factor: 5.157

4.  Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1.

Authors:  Rosalie M E Meijer van Putten; Isabella Mengarelli; Kaomei Guan; Jan G Zegers; Antoni C G van Ginneken; Arie O Verkerk; Ronald Wilders
Journal:  Front Physiol       Date:  2015-02-03       Impact factor: 4.566

5.  Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells.

Authors:  Jan Trieschmann; Moritz Haustein; Annette Köster; Jürgen Hescheler; Konrad Brockmeier; Gerardus Bennink; Tobias Hannes
Journal:  Stem Cells Int       Date:  2019-03-06       Impact factor: 5.443

6.  Inhibitory effects of class I antiarrhythmic agents on Na+ and Ca2+ currents of human iPS cell-derived cardiomyocytes.

Authors:  Sayaka Yonemizu; Keiichiro Masuda; Yasutaka Kurata; Tomomi Notsu; Yuhei Higashi; Kenta Fukumura; Peili Li; Haruaki Ninomiya; Junichiro Miake; Motokazu Tsuneto; Yasuaki Shirayoshi; Ichiro Hisatome
Journal:  Regen Ther       Date:  2019-02-01       Impact factor: 3.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.